{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-24-251240","form_type":"8-K","ticker":"ANTX","cik":"0001880438","company_name":"AN2 Therapeutics, Inc.","filed_at":"2024-11-05T23:59:59+00:00","discovered_at":"2026-05-14T18:03:10.231467+00:00","generated_at":"2026-05-30T05:29:45.657772+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"AN2 Therapeutics appoints Joshua Eizen as Chief Legal Officer and COO","bullets":["Joshua Eizen appointed Chief Legal Officer and Chief Operating Officer effective Nov 4, 2024.","Salary increased to $450,000; granted option for 63,000 shares and 31,500 RSUs.","Option vests monthly over 48 months; RSUs vest annually over 4 years.","Eizen previously served as Chief Legal Counsel; no family relationships or related-party transactions."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-24-251240","json":"https://secwatch.observer/filing/0001193125-24-251240.json","markdown":"https://secwatch.observer/filing/0001193125-24-251240.md","text":"https://secwatch.observer/filing/0001193125-24-251240.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1880438/000119312524251240/0001193125-24-251240-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1880438/000119312524251240/d872811d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T05:29:45.657772+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"55ae96c47c","claim":"Joshua Eizen was appointed as Chief Legal Officer and Chief Operating Officer at AN2 Therapeutics, Inc..","evidence_excerpt":"On November 4, 2024, the Board of Directors of AN2 Therapeutics, Inc. (the “Company”) appointed Joshua Eizen, the Company’s current Chief Legal Counsel, age 47, as Chief Legal Officer and Chief Operating Officer of the Company, effective immediately","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1880438/000119312524251240/0001193125-24-251240-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Chief Legal Officer and Chief Operating Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}